U.S. Lays Out Plans to Address Biothreats
The Obama administration unveiled a revised U.S. strategy for dealing with biological weapons proliferation and terrorism Dec. 9, altering the Bush administration’s approach in some ways but keeping the focus on the threat from bioterrorism and reaffirming the decision not to pursue a verification protocol to the Biological Weapons Convention (BWC).
Some diplomats questioned the emphases of the
Details of the
In summarizing the strategy, Tauscher said one key element was international cooperation “to combat infectious diseases regardless of their cause,” that is, whether they are “of natural, accidental or deliberate origin.”
She also said the
When the Obama administration came into office, it conducted a review and found that the
Article 10 of the BWC establishes the right of all parties to “the fullest possible exchange of equipment, materials and scientific and technological information for the use of bacteriological (biological) agents and toxins for peaceful purposes.” Article 3 bans any kind of assistance relating to “agents, toxins, weapons, equipment or means of delivery” that are part of a biological weapons program.
The Obama strategy document gives credit to the Bush administration for having “significantly expanded” programs to “recognize and respond to acts of bioterrorism or other outbreaks of infectious disease” since 2001, when, shortly after the September 11 attacks, anthrax-filled letters were delivered to congressional offices and media outlets. The document says, however, that work on preventing such threats “has received comparatively limited policy focus or substantive guidance at the National level” and needs to be increased, in particular by greater efforts to “reduce the likelihood that such an attack might occur.”
The strategy cites a range of methods for combating biological threats, including “technology watch” efforts that “provide cutting edge insight and analysis” by experts in the relevant scientific fields, export controls, and law enforcement.
In a Dec. 24 e-mail to Arms Control Today, a diplomat from a key country in the Nonaligned Movement (NAM) said the new strategy puts too much weight on “law enforcement and Article III,” considering that “the response to bioattacks (terrorism or otherwise) is based on good primary health care systems, which is more related to Article X.”
Varying Risk Assessments
In her remarks, Tauscher said that “while the
Other diplomats, however, questioned that general emphasis, as well as the specific connection to advances in life sciences. In a Dec. 18 interview, a European diplomat said science developments since the mid-1990s deal primarily with activities and technologies that are feasible for governments but not for terrorist groups.
The European diplomat responded skeptically to that statement. The actions that Tauscher listed to achieve that goal are, for the most part, “exactly what we are doing,” he said. Some of the proposed steps actually might undermine that goal, he added. For example, “engaging in more robust bilateral compliance discussions,” a step Tauscher mentioned, could be seen as “undermining the convention as the international platform,” he said.
Another element of the
Some of the language in the strategy document suggests possible reasons that the Obama administration feels the need to rely on subgroups of the BWC membership rather than on the membership as a whole. “[C]oncerns remain that some treaty partners may be developing biological weapons,” the document says. In the past, the
The strategy document also says that there is a “plurality of perspectives in the international community as to the severity of the risk and mitigative actions that nations should take” in response.
Tauscher also told the annual meeting of BWC parties that the
In announcing the decision, Tauscher said she hoped “this will not be a surprise to anyone” and cited the difficulties of verifying compliance. “The ease with which a biological weapons program could be disguised within legitimate activities and the rapid advances in biological research make it very difficult to detect violations. We believe that a protocol would not be able to keep pace with the rapidly changing nature of the biological weapons threat,” she said.
The European diplomat agreed that “there was no surprise on substance” in Tauscher’s statement on verification, but he said he thought the statement about the inability to keep pace was “not correct.” Since 2001, there have been no discussions on how scientific or other advances could help strengthen monitoring capabilities, he said.
He noted that the statement delivered at the December meeting by
ACA In The NewsPentagon to spend $1.9 bln for missile defense overhaul
March 5, 2014
House Iran Letter Leaves Out Demand For ‘Zero Enrichment’
March 4, 2014
OP-ED: Toward a Final-Phase Deal with Iran
March 4, 2014
Resolving Nuclear Arms Claims Hinges on Iran's Demand for Documents
March 1, 2014
U.S. Senate's Menendez happy in 'bad cop' role on Iran talks
February 26, 2014
Silo reduction impact study to START, despite warnings
Minot Daily News
February 22, 2014